Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant and Concurrent Chemoradiotherapy Plus Nimotuzumab in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Oropharynx and Hypopharynx

NCT01516996 is registered in ClinicalTrials.gov with The Second People's Hospital of Sichuan as lead sponsor.

NCT NCT01516996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01516996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant and Concurrent Chemoradiotherapy Plus Nimotuzumab in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Oropharynx and Hypopharynx
Lead sponsor
The Second People's Hospital of Sichuan
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2012
Completion date
March 31, 2018
Enrollment
80 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hypopharyngeal cancer, oropharyngeal cancer